|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Resident in Chest Diseases, University of Colorado School of Medicine and Fitzsimons Army Hospital, The Chest Disease Section of the Medical Service and the Research and Development Branch, Fitzsimons Army Hospital, Denver, Colorado.
2 The Chest Disease Section of the Medical Service and the Research and Development Branch, Fitzsimons Army Hospital, Denver, Colorado.
A preliminary investigation of the use of Terramycin alone and concomitantly with streptomycin in the treatment of pulmonary tuberculosis indicates that Terramycin may be valuable, particularly as an adjunctive chemotherapeutic agent, in delaying the emergence of bacterial resistance to streptomycin. Further clinical trials of Terramycin, especially in combination with streptomycin, appear warranted.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |